ASP1570 Advanced Solid Tumor Study

Study overview

This Phase 1 study is evaluating ASP1570 in participants with advanced solid tumors. “Advanced solid tumor” is a broad research term that may include different cancer types when disease has progressed or cannot be addressed adequately with standard treatment. The exact tumor types, prior-treatment requirements, laboratory results, and other eligibility conditions are defined by the study protocol.

What Phase 1 research examines

Phase 1 clinical research commonly focuses on safety, tolerability, dose selection, and how an investigational treatment behaves in the body. Researchers may monitor side effects, physical findings, laboratory results, and other protocol-defined measures. Participation involves scheduled visits and assessments that depend on the assigned study plan. ASP1570 is investigational, so its benefits and risks are not fully established. The research team explains known information, foreseeable risks, required procedures, and alternatives during informed consent.

Asking about participation

Study availability can change as cohorts open, pause, or close. A conversation with the California Research Institute team can help you understand whether screening may be appropriate. Screening does not guarantee enrollment, and contacting the institute does not obligate you to participate. Participation is voluntary, and you may discuss the study with your physician, family, or another trusted adviser before deciding.

To request current information, call (323) 660-6200 or email trials@caresinst.org. Please do not email medical records, insurance details, or other sensitive health information. This page is educational and does not replace medical advice.

The coordinator can explain visit expectations and what information is needed for an initial, confidential study inquiry.